ENDRA Life Sciences NDRA Holds Steady Near Support as MicroCap Biotech Awaits Catalysts Biotech Sector Outlook Navigating the Next Phase CUK Q1 2026 Earnings Slight EPS Miss Overshadowed by 656 Stock Rally Kazatomprom Q3 Production Surges 17 as Uranium Market Strengthens